Immune-mediated neuropathies: pathophysiology and management

A Shastri, A Al Aiyan, U Kishore… - International journal of …, 2023 - mdpi.com
Dysfunction of the immune system can result in damage of the peripheral nervous system.
The immunological mechanisms, which include macrophage infiltration, inflammation and …

European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy …

PYK Van den Bergh, PA van Doorn… - Journal of the …, 2021 - Wiley Online Library
To revise the 2010 consensus guideline on chronic inflammatory demyelinating
polyradiculoneuropathy (CIDP). Seventeen disease experts, a patient representative, and …

Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy

F Eftimov, IM Lucke, LA Querol, YA Rajabally… - Brain, 2020 - academic.oup.com
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) consists of a spectrum
of autoimmune diseases of the peripheral nerves, causing weakness and sensory …

The autoimmune vulnerability of the node of Ranvier

L Querol, E Delmont, C Lleixà - Journal of the Peripheral …, 2023 - Wiley Online Library
Abstract The nodes of Ranvier (NoR) are essential domains for nerve conduction and their
disruption plays a key role in the pathophysiology of immune‐mediated neuropathies. Our …

Autoantibodies in chronic inflammatory demyelinating polyradiculoneuropathy

E Pascual-Goñi, L Martín-Aguilar… - Current opinion in …, 2019 - journals.lww.com
The discovery of autoantibodies against nodal and paranodal proteins has proven useful in
clinical practice, has uncovered novel pathophysiological mechanisms, clinical phenotypes …

Antibody testing in neuropathy associated with anti-Myelin-Associated Glycoprotein antibodies: where we are after 40 years

N Latov - Current Opinion in Neurology, 2021 - journals.lww.com
Assays for anti-MAG antibodies by Enzyme-Linked Immunosorbent Assay can be improved
by testing for antibody binding at multiple serum dilutions, the inclusion of antigen-negative …

Challenges in the early diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy in adults: current perspectives

IN van Doorn, F Eftimov, L Wieske… - … and Clinical Risk …, 2024 - Taylor & Francis
Abstract Diagnosing Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) poses
numerous challenges. The heterogeneous presentations of CIDP variants, its mimics, and …

Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies

R Collet, M Caballero-Ávila, L Querol - Revue Neurologique, 2023 - Elsevier
Autoimmune neuropathies are a heterogeneous group of rare and disabling diseases in
which the immune system targets peripheral nervous system antigens and that respond to …

Treatment response to cyclophosphamide, rituximab, and bortezomib in chronic immune-mediated sensorimotor neuropathies: a retrospective cohort study

J Motte, AL Fisse, N Köse, T Grüter… - Therapeutic …, 2021 - journals.sagepub.com
Background: Up to 20% of patients with chronic immune-mediated sensorimotor
neuropathies (CIN) do not respond adequately to first-line therapies. However, studies on …

[HTML][HTML] Antibodies in immune-mediated peripheral neuropathies. Where are we in 2024?

JC Antoine - Revue Neurologique, 2024 - Elsevier
Over the past 30 years, about 20 antibodies have been identified in immune-mediated
neuropathies, recognizing membrane or intracellular proteins or glycolipids of neuron and …